Procept BioRobotics
(NASDAQ) PRCT
Procept BioRobotics Financials at a Glance
Market Cap
$1.47B
Revenue (TTM)
$308.05M
Net Income (TTM)
$95.57M
EPS (TTM)
$-1.72
P/E Ratio
-15.13
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$25.12
Volume
30,946
Open
$25.62
Price
$25.12
Volume
30,946
Open
$25.62
Previous Close
$25.12
Daily Range
$25.08 - $25.90
52-Week Range
$19.35 - $66.85
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$25.12
Volume
30,946
Open
$25.62
Previous Close
$25.12
Daily Range
$25.08 - $25.90
52-Week Range
$19.35 - $66.85
PRCT News
PRCT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Procept BioRobotics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
888
CEO
Larry L. Wood, MBA
Website
www.procept-biorobotics.comHeadquarters
San Jose, CA 94065, US
PRCT Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
-34%
Net Income Margin
-31%
Return on Equity
-25%
Return on Capital
-23%
Return on Assets
-19%
Earnings Yield
-6.61%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.47B
Shares Outstanding
56.39M
Volume
30.95K
Short Interest
0.00%
Avg. Volume
1.59M
Financials (TTM)
Gross Profit
$196.23M
Operating Income
$103.86M
EBITDA
$80.11M
Operating Cash Flow
$48.98M
Capital Expenditure
$9.36M
Free Cash Flow
$58.34M
Cash & ST Invst.
$286.50M
Total Debt
$51.62M
Procept BioRobotics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$76.38M
+11.9%
Gross Profit
$46.31M
+6.0%
Gross Margin
60.63%
N/A
Market Cap
$1.47B
N/A
Market Cap/Employee
$1.94M
N/A
Employees
756
N/A
Net Income
$29.84M
-58.3%
EBITDA
$21.75M
-32.4%
Quarterly Fundamentals
Net Cash
$234.89M
-7.3%
Accounts Receivable
$83.53M
+0.0%
Inventory
$70.69M
+25.9%
Long Term Debt
$51.62M
-34.1%
Short Term Debt
$0.00
-100.0%
Return on Assets
-18.81%
N/A
Return on Invested Capital
-23.48%
N/A
Free Cash Flow
$12.18M
+63.7%
Operating Cash Flow
$10.33M
+68.1%